验证数据展示
经过测试的应用
| Positive WB detected in | HeLa cells | 
| Positive IHC detected in | human breast cancer tissue,  human colon tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0  | 
推荐稀释比
| 应用 | 推荐稀释比 | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 | 
| Immunohistochemistry (IHC) | IHC : 1:50-1:200 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
发表文章中的应用
| WB | See 2 publications below | 
| IHC | See 1 publications below | 
产品信息
19971-1-AP targets c-Met (N-terminal) in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| 经测试应用 | WB, IHC, ELISA Application Description | 
| 文献引用应用 | WB, IHC | 
| 经测试反应性 | human, mouse, rat | 
| 文献引用反应性 | human, mouse | 
| 免疫原 | 
                                             Peptide 种属同源性预测 | 
                                    
| 宿主/亚型 | Rabbit / IgG | 
| 抗体类别 | Polyclonal | 
| 产品类型 | Antibody | 
| 全称 | met proto-oncogene (hepatocyte growth factor receptor) | 
| 别名 | |
| 计算分子量 | 156 kDa | 
| 观测分子量 | 140 kDa, 50 kDa | 
| GenBank蛋白编号 | NM_000245 | 
| 基因名称 | MET | 
| Gene ID (NCBI) | 4233 | 
| 偶联类型 | Unconjugated | 
| 形式 | Liquid | 
| 纯化方式 | Antigen affinity purification | 
| UNIPROT ID | P08581 | 
| 储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. | 
| 储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. | 
背景介绍
c-Met (also named as MET or HGFR) is a receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. c-Met regulates many physiological processes including proliferation, scattering, morphogenesis and survival. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Overexpression and/or mutation of c-Met has been reported in various human malignancies, including lung cancer, breast cancer, head and neck cancer, gastric cancer, colorectal cancer, bladder cancer, uterine cervix carcinoma, and esophageal carcinoma, c-Met could serve as an important therapeutic target (PMID: 26036285). This antibody recognizes the N-term of c-Met.
发表文章
| Species | Application | Title | 
|---|---|---|
Oncogene A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness. | ||
Carcinogenesis MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. | ||
Am J Pathol PIK3CG Is a Potential Therapeutic Target in Androgen Receptor-Indifferent Metastatic Prostate Cancer. | 




